Garth Rapeport is the founder and CEO of Pulmocide, an innovative venture capital funded company that specialises in tackling prevalent, but hard-to-treat respiratory infections.
The company focuses on infections associated with life-threatening... complications that can have significant effects on patients’ quality of life. A unique biopharmaceutical company, Pulmocide Ltd is identifying and developing potent inhaled antifungal and antiviral medicines for life-threatening lung conditions. These include Invasive Aspergillus, RSV (respiratory syncytial virus), asthma and cystic fibrosis.
Quality assurance is the top priority of ProvenExpert's terms of use and evaluation guidelines.
However, should you feel that a review is in violation of our guidelines, you can submit a request to have the review assessed by the ProvenExpert quality assurance team by using the following contact form.
Send email to reviewer
* Required fields
You have already posted this review on . Posting again might create duplication.
Continue?